Please wait a minute...
浙江大学学报（医学版）
Journal of ZheJiang University(Medical Science)  2015, Vol. 44 Issue (5): 517-524    DOI: 10.3785/j.issn.1008-9292.2015.09.08
    
Expression of gap junction protein connexin 26 in human hepatocellular carcinoma and its significance
YANG Yan1, LI Yu-mei1, ZHANG Na2, LI Wan-yun2, OU Yu-rong2, WANG Rui1, ZHAO Fu-you1, WU Qiong1
1. Department of Medical Oncology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China;
2. Department of Pathology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
Download:   PDF(2562KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective:To investigate the expression of gap junction protein connexin 26(Cx26) in hepatocellular carcinoma(HCC) and its significance. Methods:The expression of Cx26 in liver tissue was examined by immunohistochemistry staining in 159 paraffin-embeded liver sections, including 20 samples of normal liver tissue, 30 samples of chronic hepatitis, 33 samples of liver cirrhosis, and 76 samples of HCC. Normal hepatic cell line LO2 and HCC cell line SMMC-7721 were used in vitro to verify the characteristics of gap junction and Cx26 expression pattern. The expression and localization of Cx26 were measured by Western blotting and immunofluorescence assay, respectively. The function of gap junction between adjacent cells was detected by dye transfer assay. Results:Compared to normal liver samples, the positive rate of Cx26 was markedly decreased in hepatitis, cirrhosis and HCC tissues(all P<0.05). The intensity of Cx26 staining was significantly increased in HCC tissues compared with those in non-carcinomatous liver(NCL) tissues(all P<0.05). In NCL tissues, there was a mild to moderated staining of Cx26 which located mainly on the membranes of hepatocytes at intercellular contacts. The positive staining of Cx26 in HCC tissues was observed mainly in cytoplasm. Positive Cx26 expression was positively associated with tumor size(P=0.036), but not with age, gender, histologic grade, clinical stage, underlying hepatitis and cirhosis, lymph node metastasis and intrahepatic vascular embolism(all P>0.05). Compared with LO2 cells, an aberrant expression and distribution of Cx26 in SMMC-7721 cells was confirmed, which may lead to a decreased function of gap junctions. Conclusions:The aberrant expression and distribution of Cx26 protein may be associated with hepatocarcinogenesis, and the residual gap junction in HCC may provide a new target for treatment of HCC.

Key words： Carcinoma, hepatocellular/pathology      Connexins/genetics      Gap junctions/physiology      Immunohistochemistry      Gene expression     
Received: 07 May 2015     
CLC:  R735.7  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
YANG Yan
LI Yu-mei
ZHANG Na
LI Wan-yun
OU Yu-rong
WANG Rui
ZHAO Fu-you
WU Qiong
Cite this article:

YANG Yan, LI Yu-mei, ZHANG Na, LI Wan-yun, OU Yu-rong, WANG Rui, ZHAO Fu-you, WU Qiong. Expression of gap junction protein connexin 26 in human hepatocellular carcinoma and its significance. Journal of ZheJiang University(Medical Science), 2015, 44(5): 517-524.

URL:

http://www.zjujournals.com/xueshu/med/10.3785/j.issn.1008-9292.2015.09.08     OR     http://www.zjujournals.com/xueshu/med/Y2015/V44/I5/517


缝隙连接蛋白26在肝细胞癌组织的表达及意义

目的:研究缝隙连接蛋白26(Cx26)在人肝细胞癌(HCC)组织中的表达程度及定位,探讨该基因在HCC发生中的作用。方法:应用免疫组织化学染色法检测159份肝脏石蜡包埋组织中Cx26蛋白的表达和定位,其中正常肝组织20份、肝炎30份、肝硬化33份,HCC 76份。另在体外使用人正常肝细胞株LO2和肝癌细胞株SMMC-7721,采用蛋白质印迹法和免疫荧光法检测Cx26蛋白表达和定位,细胞接种荧光示踪法检测缝隙连接功能。结果:与正常肝组织比较,肝炎、肝硬化和HCC组织中Cx26蛋白阳性表达率显著下降(均P<0.05)。Cx26蛋白表达强度在HCC中明显高于非癌肝组织(均P<0.05)。非癌肝组织Cx26多呈轻中度表达,主要定位于相邻细胞间相互接触的细胞膜上,偶见于细胞质;而HCC组织中阳性表达的Cx26染色多较强,且多数定位于细胞质,偶见于细胞膜。Cx26蛋白与肿瘤大小呈正相关(P<0.05),而与年龄、性别、肿瘤病理分级、TNM分期、伴肝炎肝硬化、淋巴结转移及脉管癌栓无明显相关(均P>0.05)。体外实验进一步证实,与LO2细胞比较,SMMC-7721肝癌细胞存在Cx26蛋白表达降低及分布异常,并且功能性缝隙连接明显下调。结论:Cx26蛋白的表达及定位异常可能与HCC的发生有关,HCC中残存的缝隙连接可能成为抗肝癌治疗新靶点。


关键词： 癌,  肝细胞/病理学,  连接蛋白类/遗传学,  缝隙接合部/生理学,  免疫组织化学,  基因表达 
[[1]]   VERSLYPE C, ROSMORDUC O, ROUGIER P; ESMO Guidelines Working Group. Hepatocellular carcinoma:ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol, 2012,23(Suppl 7):vii41-48.
[[2]]   中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肿瘤学杂志,2011,16(10):929-946. Ministry of Health of the People's Republic of China.Primary liver cancer diagnosis and treatment standard(2011 Edition)[J]. Chinese Clinical Oncology, 2011,16(10):929-946.(in Chinese)
[[3]]   MAES M, DECROCK E,COGLIATI B,et al. Connexin and pannexin(hemi)channels in the liver[J]. Front Physiol, 2014,4:405.
[[4]]   NAKASHIMA Y, ONO T, YAMANOI A, et al. Expression of gap junction protein connexin 32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma[J]. J Gastroenterol, 2004,39(8):763-768.
[[5]]   LI Q, OMORI Y, NISHIKAWA Y, et al. Cytoplasmic accumulation of connexin 32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo[J]. Int J Cancer, 2007,121(3):536-546.
[[6]]   OMORI Y, LI Q, NISHIKAWA Y, et al. Pathological significance of intracytoplasmic connexin proteins:implication in tumor progression[J]. J Membr Biol, 2007,218(1-3):73-77.
[[7]]   VINKEN M, VANHAECKE T, PAPELEU P, et al. Connexins and their channels in cell growth and cell death[J]. Cell Signal, 2006,18(5):592-600.
[[8]]   杨 燕,吴 穷,郑荣生,等.CX26/CX32缝隙连接蛋白的Tet-on HeLa细胞模型的建立及鉴定[J].基础医学与临床, 2013,33(9):1079-1084. YANG Yan, WU Qiong, ZHENG Rong-sheng, et al. Establishment and identification of a Tet-on HeLa cell model of CX26/CX32 gap junction[J]. Basic & Clinical Medicine, 2013,33(9):1079-1084.(in Chinese)
[[9]]   YANG Y, QIN S K, WU Q, et al. Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition[J]. Oncol Rep, 2014,31(2):540-550.
[[10]]   MESNIL M, CRESPIN S, AVANZO J L, et al. Defective gap junctional intercellular communication in the carcinogenic process[J]. Biochim Biophys Acta, 2005,1719(1-2):125-145.
[[11]]   LEITHE E, SIRNES S, OMORI Y, et al. Downregulation of gap junctions in cancer cells[J]. Crit Rev Oncog, 2006,12(3-4):225-256.
[[12]]   MOMIYAMA M, OMORI Y, ISHIZAKI Y, et al. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells[J]. Cancer Sci, 2003,94(6):501-507.
[[13]]   LIU C L, HUANG Y S, HOSOKAWA M, et al. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication[J]. Chem Biol Interact, 2009,182(2-3):165-172.
[[14]]   POINTIS G, SEGRETAIN D.Role of connexin-based gap junction channels in testis[J]. Trends Endocrinol Metab, 2005,16(7):300-306.
[[15]]   RUTTINGER C, BERGMANN M, FINK L, et al. Expression of connexin 43 in normal canine testes and canine testicular tumors[J]. Histochem Cell Biol, 2008,130(3):537-548.
[[16]]   UDAKA N, MIYAGI Y, ITO T. Connexin expression in mouse lung tumor[J]. Cancer Lett, 2007,246(1-2):224-229.
[[17]]   ITO A, KOMA Y, UCHINO K, et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma:significant correlation with poor prognosis[J]. Cancer Lett, 2006,234(2):239-248.
[[18]]   JAMIESON S, GOING J J, D'ARCY R,et al. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours[J]. J Pathol, 1998,184(1):37-43.
[[19]]   ZHAI Y, WU R,SCHWARTZ D R, et al. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas[J]. Am J Pathol, 2002,160(4):1229-1238.
[[20]]   SAUNDERS M M, SERAJ M J, LI Z, et al. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication[J]. Cancer Res, 2001,61(5):1765-1767.
[[21]]   TSUJIUCHI T, SHIMIZU K, ITSUZAKI Y, et al. CpG site hypermethylation of E-cadherin and Connexin 26 genes in hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats. Mol Carcinog, 2007,46(4):269-274.
[[22]]   PLANTE I, CHARBONNEAU M, CYR D G. Decreased gap junctional intercellular communication in hexachlorobenzene-induced gender-specific hepatic tumor formation in the rat[J]. Carcinogenesis, 2002,23(7):1243-1249.
[[23]]   WANG Z S, WU L Q,YI X, et al. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy[J]. BMC Cancer, 2013,13:306.
[[24]]   YANO T, HERNANDEZ-BLAZQUEZ F J, OMORI Y, et al. Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32[J]. Carcinogenesis, 2001,22(10):1593-1600.
[[25]]   ZHAO J Q, SUN F J, LIU S S, et al. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients[J].Asian Pac J Cancer Prev, 2013,14(2):639-643.
[1] CAI Cheng,WANG Jianping,ZHONG Zhifeng,DAI Zhihui,WANG Qinghua,DONG Wuzhen,SHI Hongqi,LIU Qingwei,DU Jinlin. Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 36-43.
[2] HOU Shifang, WANG Zhihua, WANG Jun, HE Zhixu, SHU Liping. Myeloid and erythroid hematopoietic transcription factor expression decline after knockdown of lmna genes in zebrafish embryos[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 620-625.
[3] WU Zhihua, JING Min, LIANG Hanying, YANG Rong, HUANG Yaping, CHEN Xiaoming, HU Jianhua, FAN Jun. T cell receptor β-chain CDR3 spectratyping and cytomegalovirus activation in allogeneic hematopoietic stem cell transplant recipients[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 515-521.
[4] ZHENG Jiangjiang, ZHU Yin, LI Changshui, LI Yinya, NIE Qianqian, ZHU Ziling, DENG Hong. Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 335-341.
[5] CHEN Xiaojing, XU Junfen, YE Jing, CHENG Xiaodong, XIE Xing, LYU Weiguo. Expression of miR-let-7e-3p in cervical intraepithelial neoplasm and cervix carcinoma and its clinical significance[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 342-348.
[6] WANG Cheng, WANG Wenjun, YANG Wei, YU Xiaohua, YAN Yiguo, ZHANG Jian, JIANG Zhisheng. MicroRNAs: a type of novel regulative factor for intervertebral disc degeneration[J]. Journal of ZheJiang University(Medical Science), 2016, 45(2): 170-178.
[7] LAI Maode. Gastroenteropancreatic neuroendocrine neoplasms: concepts and related issues[J]. Journal of ZheJiang University(Medical Science), 2016, 45(1): 5-9,23.
[8] LIN Kai-qing, ZHU Li-bo, ZHANG Xin-mei, LIN Jun. Role of mast cells in estrogen-mediated experimental endometriosis in rats[J]. Journal of ZheJiang University(Medical Science), 2015, 44(3): 269-277.
[9] LIU Xue-hong, ZHANG Yong, LIU Chuan-kang. Expression of neuron-specific enolase and synaptophysin in esophageal development of human embryos[J]. Journal of ZheJiang University(Medical Science), 2015, 44(2): 184-188.
[10] TONG Xu-hui, GU Yu-chen, JIAO Hao, YU Li, DONG Shu-ying. Inhibition of gap junctional intercellular communication protects astrocytes from hypoxia/reoxygenation injury[J]. Journal of ZheJiang University(Medical Science), 2015, 44(1): 67-73.
[11] LIU Yan-ru, ZHANG Rui-feng, YING Ke-jing. Roles of long noncoding RNA in lung cancer[J]. Journal of ZheJiang University(Medical Science), 2014, 43(5): 607-.
[12] MIAO Hua，et al. Molecular classification of colorectal carcinoma based on integration of gene expression profile and copy number variation [J]. Journal of ZheJiang University(Medical Science), 2014, 43(4): 420-426.
[13] JIN Shu-qing，et al. Correlation of PBX2/ELF2 expression with prognosis of non-small cell lung cancer[J]. Journal of ZheJiang University(Medical Science), 2014, 43(4): 413-419.
[14] CAO Pei-long，et al. Expressions of FOXC1 and MMP-7 in molecular subtypes of breast cancer and their association with clinicopathological characteristics [J]. Journal of ZheJiang University(Medical Science), 2014, 43(4): 406-412.
[15] OU Yu-rong，et al. Expression of secreted frizzled related protein 1，β-catenin and E-cadherin in colorectal carcinoma and its clinicopathological significances [J]. Journal of ZheJiang University(Medical Science), 2014, 43(4): 397-405.